Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
This quick comparison outlines safety essentials between stablecoins and other crypto assets, with practical tips for cautious investors.
21,083 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Yum! Brands is selling Pizza Hut in two moves, reshaping its portfolio. This could boost balance sheet strength and s...
"forget magnificent seven. this" is a line gaining traction as an equal-weight S&P 500 fund outperforms the cap-weigh...
In 2026, AMD has taken the lead in the chip market while Nvidia hasn’t kept pace. This piece breaks down why, what co...
As conflicts persist around the globe, households feel the bill. Experts say the true cost goes beyond weapons, shapi...
Two sector income ETFs are delivering yields well above the S&P 500 as investors price in a possible recession. The g...
Retirement is a high-stakes puzzle. Learn practical strategies to coordinate social security, RMDs, and Roth conversi...
Cloudflare surged about 9% in midday trading after a Scotiabank upgrade. The move comes as AI cloud peers like Oracle...
A calmer catastrophe year can boost underwriting margins and reserve efficiency. This piece explains why allstate hav...
Nvidia just landed a significant AI deal that could shift its growth trajectory. This article breaks down what invest...
A single Vanguard ETF has quietly led the charge over the past ten years by keeping costs ultra-low and sticking to t...
What if a smart, data-backed ETF choice could help you finish 2026 with solid returns from the S&P 500? This guide br...